Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy

International Archives of Allergy and Immunology

Volumn 154, Issue 4, 2011, Pages 318-327

  Gernez, Yael ^a   Tirouvanziam, Rabindra ^a   Yu, Grace ^a   Ghosn, Eliver E B ^a   Reshamwala, Neha ^a   Nguyen, Tammie ^a   Tsai, Mindy ^a   Galli, Stephen J ^a   Herzenberg, Leonard A ^a   Herzenberg, Leonore A ^a   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylaxis; Atopic; CD203c; Cockroach allergen; Flow cytometry; Human basophils; Omalizumab; Peanut allergy; Tree nut allergy

Indexed keywords

CD11B ANTIGEN; CD123 ANTIGEN; CD203C ANTIGEN; CD294 ANTIGEN; CD63 ANTIGEN; IMMUNOGLOBULIN E; MEMBRANE ANTIGEN; OMALIZUMAB; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BASOPHIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PEANUT ALLERGY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; BASOPHILS; BIOLOGICAL MARKERS; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; MALE; NUT HYPERSENSITIVITY; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77958113930     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321824     Document Type: Article

References (42)

1. Burks AW: Peanut allergy. Lancet 2008;371:1538-1546.
2. Sicherer SH, Sampson HA: 9. Food allergy. J Allergy Clin Immunol 2006;117:S470-S475.
3. Cox L, Williams B, Sicherer S, Oppenheimer J, Sher L, Hamilton R, Golden D: Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force. Ann Allergy Asthma Immunol 2008;101:580-592.
4. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW: Successful oral tolerance induction in severe peanut allergy. Allergy 2009;64:1218-1220.
5. Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, Shreffler WG, Steele P, Henry KA, Adair M, Francis JM, Durham S, Vickery BP, Zhong X, Burks AW: Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009;124:292-300, 300, e291-e297.
6. Leung DY, Sampson HA, Yunginger JW, Burks AW Jr, Schneider LC, Wortel CH, Davis FM, Hyun JD, Shanahan WR Jr: Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003;348:986-993. (Pubitemid 36302243)
7. Hamilton RG, Marcotte GV, Saini SS: Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (xolair) therapy. J Immunol Methods 2005;303:81-91. (Pubitemid 41169948)
8. MacGlashan D Jr: Therapeutic efficacy of omalizumab. J Allergy Clin Immunol 2009;123:114-115.
9. Buhring HJ, Streble A, Valent P: The basophil-specific ectoenzyme e-npp3 (cd203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol 2004;133:317-329. (Pubitemid 38490210)
10. Aerts NE, Dombrecht EJ, Bridts CH, Hagendorens MM, de Clerck LS, Stevens WJ, Ebo DG: Simultaneous flow cytometric detection of basophil activation marker cd63 and intracellular phosphorylated p38 mitogen-activated protein kinase in birch pollen allergy. Cytometry B Clin Cytom 2008;76B:8-17.
11. Kleine-Tebbe J, Erdmann S, Knol EF, MacGlashan DW Jr, Poulsen LK, Gibbs BF: Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int Arch Allergy Immunol 2006;141:79-90.
12. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, Leung DY, Lotvall J, Marone G, Metcalfe DD, Muller U, Rosenwasser LJ, Sampson HA, Schwartz LB, van Hage M, Walls AF: Practical Allergy (PRACTALL) report: risk assessment in anaphylaxis. Allergy 2008;63:35-37. (Pubitemid 350198250)
13. Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F, Girot R: Comparison of two basophil activation markers CD63 and CD203C in the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008;38:921-928. (Pubitemid 351725844)
14. de Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, Demoly P, Ebo DG, Mayorga L, Monneret G, Sainte-Laudy J: Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008;146:177-189. (Pubitemid 351832459)
15. Fujisawa T, Nagao M, Hiraguchi Y, Hosoki K, Tokuda R, Usui S, Masuda S, Shinoda M, Hashiguchi A, Yamaguchi M: Biomarkers for allergen immunotherapy in cedar pollinosis. Allergol Int 2009;58:163-170.
16. Nagao M, Hiraguchi Y, Hosoki K, Tokuda R, Usui T, Masuda S, Yamaguchi M, Fujisawa T: Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with japanese cedar pollinosis. Int Arch Allergy Immunol 2008;146(suppl 1):47-53.
17. Ocmant A, Mulier S, Hanssens L, Goldman M, Casimir G, Mascart F, Schandene L: Basophil activation tests for the diagnosis of food allergy in children. Clin Exp Allergy 2009;39:1234-1245.
18. Tokuda R, Nagao M, Hiraguchi Y, Hosoki K, Matsuda T, Kouno K, Morita E, Fujisawa T: Antigen-induced expression of CD203c on basophils predicts IgE-mediated wheat allergy. Allergol Int 2009;58:193-199.
19. Wanich N, Nowak-Wegrzyn A, Sampson HA, Shreffler WG: Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol 2009;123:789-794, e720.
20. Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, Bock SA, Sicherer SH, Teuber SS: Work group report: oral food challenge testing. J Allergy Clin Immunol 2009;123:S365-S383.
21. Gibbs BF, Plath KE, Wolff HH, Grabbe J: Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-kinase inhibitors and calcium mobilization. J Leukoc Biol 2002;72:391-400.
22. Miller RL, Eppinger TM, McConnell D, Cunningham-Rundles C, Rothman P: Analysis of cytokine signaling in patients with extrinsic asthma and hyperimmunoglobulin E. J Allergy Clin Immunol 1998;102:503-511. (Pubitemid 28471514)
23. Hamilton RG, Franklin Adkinson N Jr: In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol 2004;114:213-225; quiz 226.
24. Herzenberg LA: FACS innovation: a view from Stanford. Clin Invest Med 2004;27:240-252.
25. Tung JW, Heydari K, Tirouvanziam R, Sahaf B, Parks DR, Herzenberg LA: Modern flow cytometry: a practical approach. Clin Lab Med 2007;27:453-468, v.
26. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
27. Ghosn EE, Yang Y, Tung J, Herzenberg LA: CD11b expression distinguishes sequential stages of peritoneal b-1 development. Proc Natl Acad Sci USA 2008;105:5195-5200. (Pubitemid 351738533)
28. Buhring HJ, Seiffert M, Giesert C, Marxer A, Kanz L, Valent P, Sano K: The basophil activation marker defined by antibody 97a6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood 2001;97:3303-3305.
29. Gubina E, Luo X, Kwon E, Sakamoto K, Shi YF, Mufson RA: Betac cytokine receptor-induced stimulation of camp response element binding protein phosphorylation requires protein kinase c in myeloid cells: a novel cytokine signal transduction cascade. J Immunol 2001;167:4303-4310. (Pubitemid 32954305)
30. Didichenko SA, Spiegl N, Brunner T, Dahinden CA: IL-3 induces a PIM1-dependent antiapoptotic pathway in primary human basophils. Blood 2008;112:3949-3958.
31. MacGlashan D Jr, Lichtenstein LM, McKenzie- White J, Chichester K, Henry AJ, Sutton BJ, Gould HJ: Upregulation of FCεRI on human basophils by IgE antibody is mediated by interaction of IgE with FCεRI. J Allergy Clin Immunol 1999;104:492-498. (Pubitemid 29420453)
32. Park BL, Kim LH, Choi YH, Lee JH, Rhim T, Lee YM, Uh ST, Park HS, Choi BW, Hong SJ, Park CS, Shin HD: Interleukin 3 (IL3) polymorphisms associated with decreased risk of asthma and atopy. J Hum Genet 2004;49:517-527. (Pubitemid 39506535)
33. Bhoumik A, Ronai Z: ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities. Cell Cycle 2008;7:2341-2345.
34. Shore P, Bisset L, Lakey J, Waltho JP, Virden R, Sharrocks AD: Characterization of the ELK-1 ETS DNA-binding domain. J Biol Chem 1995;270:5805-5811.
35. Ebo DG, Bridts CH, Hagendorens MM, Aerts NE, De Clerck LS, Stevens WJ: Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin Cytom 2008;74:201-210. (Pubitemid 352007317)
36. Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R, Harbeck RJ: Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 2006;117:1430-1434. (Pubitemid 43795743)
37. Chirumbolo S, Conforti A, Ortolani R, Vella A, Marzotto M, Bellavite P: Stimulus-specific regulation of CD63 and CD203c membrane expression in human basophils by the flavonoid quercetin. Int Immunopharmacol 2010;10:183-192.
38. Ocmant A, Peignois Y, Mulier S, Hanssens L, Michils A, Schandene L: Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy. J Immunol Methods 2007;320:40-48. (Pubitemid 46349100)
39. Ono E, Taniguchi M, Higashi N, Mita H, Kajiwara K, Yamaguchi H, Tatsuno S, Fukutomi Y, Tanimoto H, Sekiya K, Oshikata C, Tsuburai T, Tsurikisawa N, Otomo M, Maeda Y, Hasegawa M, Miyazaki E, Kumamoto T, Akiyama K: CD203c expression on human basophils is associated with asthma exacerbation. J Allergy Clin Immunol 2010;125:483-489, e483.
40. Tokuda R, Nagao M, Hiraguchi Y, Hosoki K, Matsuda T, Kouno K, Morita E, Fujisawa T: Antigen-induced expression of CD203c on basophils predicts IgE-mediated wheat allergy. Allergol Int 2009;58:193-199.
41. Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, Carbone DP, Liu FT, Galli SJ, Kawakami T: Regulation of mast cell survival by IgE. Immunity 2001;14:791-800. (Pubitemid 32592425)
42. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM: Down-regulation of FCεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-1445. (Pubitemid 127469971)